MSH2 and endometrial cancer: Endometrial cancer is most strongly associated with PVs in MLH1, MSH2, and MSH6, which confer a lifetime risk of endometrial cancer of 34-54%, 21-57%, and 16-49%, respectively (3–5, 12).